• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫氧还蛋白系统:癌症药物开发的有前途的靶点。

The Thioredoxin System: A Promising Target for Cancer Drug Development.

机构信息

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, 9190401, Israel.

出版信息

Chemistry. 2020 Aug 12;26(45):10175-10184. doi: 10.1002/chem.201905792. Epub 2020 Jun 15.

DOI:10.1002/chem.201905792
PMID:32097513
Abstract

The thioredoxin system is highly conserved system found in all living cells and comprises NADPH, thioredoxin, and thioredoxin reductase. This system plays a critical role in preserving a reduced intracellular environment, and its involvement in regulating a wide range of cellular functions makes it especially vital to cellular homeostasis. Its critical role is not limited to healthy cells, it is also involved in cancer development, and is overexpressed in many cancers. This makes the thioredoxin system a promising target for cancer drug development. As such, over the last decade, many inhibitors have been developed that target the thioredoxin system, most of which are small molecules targeting the thioredoxin reductase C-terminal redox center. A few inhibitors of thioredoxin have also been developed. We believe that more efforts should be invested in developing protein/peptide-based inhibitors against both thioredoxin reductase and/or thioredoxin.

摘要

硫氧还蛋白系统是一种高度保守的系统,存在于所有活细胞中,由 NADPH、硫氧还蛋白和硫氧还蛋白还原酶组成。该系统在维持还原的细胞内环境中起着关键作用,其参与调节广泛的细胞功能使其对细胞内稳态尤为重要。它的关键作用不仅限于健康细胞,它还参与癌症的发展,并在许多癌症中过度表达。这使得硫氧还蛋白系统成为癌症药物开发的有前途的靶点。因此,在过去十年中,已经开发出许多针对硫氧还蛋白系统的抑制剂,其中大多数是针对硫氧还蛋白还原酶 C 端氧化还原中心的小分子。也开发了一些针对硫氧还蛋白的抑制剂。我们认为,应该投入更多的努力来开发针对硫氧还蛋白还原酶和/或硫氧还蛋白的基于蛋白质/肽的抑制剂。

相似文献

1
The Thioredoxin System: A Promising Target for Cancer Drug Development.硫氧还蛋白系统:癌症药物开发的有前途的靶点。
Chemistry. 2020 Aug 12;26(45):10175-10184. doi: 10.1002/chem.201905792. Epub 2020 Jun 15.
2
Thioredoxin system - a novel therapeutic target.硫氧还蛋白系统——一个新的治疗靶点。
Gen Physiol Biophys. 2015 Jul;34(3):221-33. doi: 10.4149/gpb_2015006. Epub 2015 Apr 30.
3
Targeting the Thioredoxin System for Cancer Therapy.靶向硫氧还蛋白系统治疗癌症。
Trends Pharmacol Sci. 2017 Sep;38(9):794-808. doi: 10.1016/j.tips.2017.06.001. Epub 2017 Jun 22.
4
The thioredoxin system and cancer therapy: a review.硫氧还蛋白系统与癌症治疗:综述。
Cancer Chemother Pharmacol. 2019 Nov;84(5):925-935. doi: 10.1007/s00280-019-03912-4. Epub 2019 Jul 31.
5
The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy.硫氧还蛋白还原酶/硫氧还蛋白系统:癌症治疗的新型氧化还原靶点。
Cancer Biol Ther. 2005 Jan;4(1):6-13. doi: 10.4161/cbt.4.1.1434. Epub 2004 Jan 8.
6
Novel strategies for targeting the thioredoxin system for cancer therapy.针对癌症治疗的硫氧还蛋白系统的新策略。
Expert Opin Drug Discov. 2022 May;17(5):437-442. doi: 10.1080/17460441.2022.2045270. Epub 2022 Feb 27.
7
Physiological functions of thioredoxin and thioredoxin reductase.硫氧还蛋白和硫氧还蛋白还原酶的生理功能。
Eur J Biochem. 2000 Oct;267(20):6102-9. doi: 10.1046/j.1432-1327.2000.01701.x.
8
Thioredoxin signaling as a target for cancer therapy.硫氧还蛋白信号传导作为癌症治疗的靶点。
Curr Opin Pharmacol. 2007 Aug;7(4):392-7. doi: 10.1016/j.coph.2007.04.003. Epub 2007 Jul 3.
9
Methanosarcina acetivorans utilizes a single NADPH-dependent thioredoxin system and contains additional thioredoxin homologues with distinct functions.嗜乙酸甲烷八叠球菌利用单一的依赖于NADPH的硫氧还蛋白系统,并含有具有不同功能的其他硫氧还蛋白同源物。
Microbiology (Reading). 2017 Jan;163(1):62-74. doi: 10.1099/mic.0.000406. Epub 2017 Feb 8.
10
Properties and biological activities of thioredoxins.硫氧还蛋白的特性与生物活性。
Annu Rev Pharmacol Toxicol. 2001;41:261-95. doi: 10.1146/annurev.pharmtox.41.1.261.

引用本文的文献

1
2D and 3D anticancer activity of diiron bis-cyclopentadienyl complexes incorporating flurbiprofen and chlorambucil.含有氟比洛芬和苯丁酸氮芥的二铁双环戊二烯基配合物的二维和三维抗癌活性
RSC Med Chem. 2025 May 6. doi: 10.1039/d4md01011f.
2
Investigation of the anticancer potential of bis(imino)acenaphthene-N-heterocyclic carbene transition metal complexes revealed TrxR inhibition and triggering of immunogenic cell death (ICD) for allyl palladates.对联萘二亚胺-N-杂环卡宾过渡金属配合物的抗癌潜力研究表明,烯丙基钯酸盐具有硫氧还蛋白还原酶(TrxR)抑制作用并能引发免疫原性细胞死亡(ICD)。
RSC Med Chem. 2025 Mar 19. doi: 10.1039/d5md00039d.
3
Gold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer.
基于非甾体类抗炎衍生物的金(I)配合物作为治疗结肠癌的多靶药物。
Inorg Chem. 2024 Oct 21;63(42):19769-19782. doi: 10.1021/acs.inorgchem.4c02988. Epub 2024 Oct 10.
4
Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications.探索硫氧还蛋白系统作为癌症治疗靶点:机制与意义
Antioxidants (Basel). 2024 Sep 4;13(9):1078. doi: 10.3390/antiox13091078.
5
A thioredoxin with cell adhesion and antioxidant function.一种具有细胞黏附与抗氧化功能的硫氧还蛋白。
Front Cell Infect Microbiol. 2024 Aug 15;14:1404120. doi: 10.3389/fcimb.2024.1404120. eCollection 2024.
6
Oxidative cell death in cancer: mechanisms and therapeutic opportunities.癌症中的氧化细胞死亡:机制与治疗机遇
Cell Death Dis. 2024 Aug 1;15(8):556. doi: 10.1038/s41419-024-06939-5.
7
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.硫氧还蛋白系统通过氧化还原介导的核糖核苷酸还原酶活性调节来决定 CHK1 抑制剂的敏感性。
Nat Commun. 2024 May 31;15(1):4667. doi: 10.1038/s41467-024-48076-9.
8
Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions.二硫化物诱导的细胞死亡解析:探索细胞死亡之谜、调控网络、疾病模式及未来方向之旅
Biomark Res. 2024 Apr 29;12(1):45. doi: 10.1186/s40364-024-00593-x.
9
Study of metalation of thioredoxin by gold(I) therapeutic compounds using combined liquid chromatography/capillary electrophoresis with inductively coupled plasma/electrospray MS/MS detection.使用结合液相色谱/毛细管电泳与电感耦合等离子体质谱/电喷雾串联质谱联用检测研究金(I)治疗化合物对硫氧还蛋白的金属化作用。
Anal Bioanal Chem. 2024 May;416(11):2819-2833. doi: 10.1007/s00216-024-05140-z. Epub 2024 Jan 20.
10
Inflammation-Associated Cytotoxic Agents in Tumorigenesis.肿瘤发生过程中与炎症相关的细胞毒性因子
Cancers (Basel). 2023 Dec 22;16(1):81. doi: 10.3390/cancers16010081.